{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-019500","form_type":"8-K","ticker":"SLNO","cik":"0001484565","company_name":"SOLENO THERAPEUTICS INC","filed_at":"2024-01-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.301031+00:00","generated_at":"2026-06-06T14:54:04.036126+00:00","sec_items":["5.02","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Soleno Therapeutics expands inducement equity plan by 500,000 shares for new hires","bullets":["Board added 500,000 shares to 2020 Inducement Plan on January 24, 2024.","Plan used to grant equity awards as material inducement for new employees and M&A hires.","Amendment adopted without stockholder approval under Nasdaq Listing Rule 5635(c)(4).","Total shares authorized under the Plan now 2,500,000."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-019500","json":"https://secwatch.observer/filing/0001193125-24-019500.json","markdown":"https://secwatch.observer/filing/0001193125-24-019500.md","text":"https://secwatch.observer/filing/0001193125-24-019500.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1484565/000119312524019500/0001193125-24-019500-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1484565/000119312524019500/d721921d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T14:54:04.036126+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}